
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Showing 18 citing articles:
Role of Radiomics-based Multiomics Panel in the Microenvironment and Prognosis of Hepatocellular Carcinoma
Ziqian Wu, Siyu Ouyang, Jidong Gao, et al.
Academic Radiology (2025)
Closed Access
Ziqian Wu, Siyu Ouyang, Jidong Gao, et al.
Academic Radiology (2025)
Closed Access
m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis
Yuze Wu, Yuheng Yan, Yarong Guo, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Yuze Wu, Yuheng Yan, Yarong Guo, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
The Emerging Role of Histotripsy in Liver Cancer Treatment: A Scoping Review
Heineken Queen, Sarah F. Ferris, Clifford S. Cho, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 915-915
Open Access
Heineken Queen, Sarah F. Ferris, Clifford S. Cho, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 915-915
Open Access
The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics
Hong‐Yi Lin, Ah‐Jung Jeon, Kaina Chen, et al.
British Journal of Cancer (2025)
Open Access
Hong‐Yi Lin, Ah‐Jung Jeon, Kaina Chen, et al.
British Journal of Cancer (2025)
Open Access
Redefining Hepatocellular Carcinoma Treatment: Nanotechnology Meets Tumor Immune Microenvironment
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access
Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
Toru Nakamura, Atsutaka Masuda, Dan Nakano, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 428-428
Open Access
Toru Nakamura, Atsutaka Masuda, Dan Nakano, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 428-428
Open Access
Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Integrating Omics: A New Paradigm in the Management of Hepatocellular Carcinoma
Aymen Bahsoun, Hero K. Hussain
Academic Radiology (2025)
Closed Access
Aymen Bahsoun, Hero K. Hussain
Academic Radiology (2025)
Closed Access
RNF2 induces myeloid-derived suppressor cells chemotaxis and promotes hepatocellular carcinoma progression through the TRAF2-NF-κB signaling axis
Manman Liang, Jianghua Yang, Aiping Zhang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
Manman Liang, Jianghua Yang, Aiping Zhang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
Immunogenic cell death genes in single-cell and transcriptome analyses perspectives from a prognostic model of cervical cancer
Ning Li, Li Xiu, Yating Xu, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Ning Li, Li Xiu, Yating Xu, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Remodeling the Tumor Immune Microenvironment through Hydrogel Encapsulated G-Rh2 In Situ Vaccine and Systemic Immunotherapy
Chunhua Li, Dan Lei, Yudong Huang, et al.
Materials Today Bio (2024) Vol. 29, pp. 101281-101281
Open Access | Times Cited: 4
Chunhua Li, Dan Lei, Yudong Huang, et al.
Materials Today Bio (2024) Vol. 29, pp. 101281-101281
Open Access | Times Cited: 4
Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells
Haoying Yang, Bolei Dai, Liangjie Chen, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1407-1407
Open Access | Times Cited: 2
Haoying Yang, Bolei Dai, Liangjie Chen, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1407-1407
Open Access | Times Cited: 2
Personalized nanovaccines for treating solid cancer metastases
Feng Tang, Jia Hu, Jirui Wen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Feng Tang, Jia Hu, Jirui Wen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Application of nanotechnology in the treatment of hepatocellular carcinoma
Liu Cai, Yanyuan Du, Hongtai Xiong, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Liu Cai, Yanyuan Du, Hongtai Xiong, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Subverting Attachment to Prevent Attacking: Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion
Marta Mastrogiovanni, Emmanuel Donnadieu, Rajiv Pathak, et al.
Biology (2024) Vol. 13, Iss. 11, pp. 860-860
Open Access
Marta Mastrogiovanni, Emmanuel Donnadieu, Rajiv Pathak, et al.
Biology (2024) Vol. 13, Iss. 11, pp. 860-860
Open Access
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver
Luca Marzi, Andrea Mega, C Turri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11676-11676
Open Access
Luca Marzi, Andrea Mega, C Turri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11676-11676
Open Access
Stage-Specific Transcriptome Landscape of Hepatocellular Carcinoma: Insights from Super and Poor Survivors with Prognostic Signature Identification
Xiaoqian Xu, Hao Wang, Lichen Shi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Xiaoqian Xu, Hao Wang, Lichen Shi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
[Ferroptosis inducer Erastin inhibits proliferation of liver cancer cells
Pan Zhao, Zihui Zhou, Liang Yu, et al.
PubMed (2024) Vol. 44, Iss. 11, pp. 2131-2136
Closed Access
Pan Zhao, Zihui Zhou, Liang Yu, et al.
PubMed (2024) Vol. 44, Iss. 11, pp. 2131-2136
Closed Access